Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122571) titled 'Effects of different blood purification treatments on health status in hemodialysis patients' on April 15.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Peking University Third Hospital
Condition:
End-Stage Renal Disease
Intervention:
Patients were divided into four groups according to blood purification modality: Group 1 received conventional HD alone
Group 2 received HD combined with HP (with no restriction on treatment frequency)
Group 3 received HD combined with HDF (with no restriction on treatment frequency)
Recruitment Status: Not Recruiting
Phase: N/A
Date of Fir...